Picture of Vicore Pharma Holding AB logo

VICO — Vicore Pharma Holding AB News Story

0.000.00%
se flag iconLast trade - 00:00
HealthcareSpeculativeSmall CapSucker Stock

Brief: Vicore Pharma Receives Approval To Start Phase IIa Study

April 18 (Reuters) - VICORE PHARMA HOLDING AB  VICOR.ST :
    * VICORE PHARMA RECEIVES APPROVAL TO START PHASE IIA STUDY
IN IPF
    * APPROVAL FROM BRITISH MEDICINES AGENCY MHRA AND ETHICS
COMMITTEE
FOR LONDON AND SURREY FOR PHASE IIA STUDY ON IPF

Source text for Eikon:  ID:nWkr3DlQZ5 
Further company coverage:  VICOR.ST 

 (Gdynia Newsroom)
 ((gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))

Recent news on Vicore Pharma Holding AB

See all news